← Leaderboards
Monique Marie Hedderson
University Of Pittsburgh At Pittsburgh
$17,343,525
Attributed
$39,321,331
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $18.5M · FY2010–25$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$82,105,987 · 11
By mechanism
U19$42,784,656 · 1
R01$17,212,357 · 6
UG3$12,642,705 · 2
UH3$9,466,269 · 2
Top collaborators
- Jose Carlos Florez10 shared
- Maria Mori Brooks8 shared
- Carol A Derby8 shared
- Imke Janssen8 shared
- Arun S. Karlamangla8 shared
- Rebecca C Thurston8 shared
- L Elaine Waetjen8 shared
- Sherri-Ann M Burnett-Bowie7 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Charles R Rinaldo$100,535,685
- Robbie B Mailliard$3,953,563
- Stephanie D Stepp$8,171,760
- Nadine M. Melhem$18,044,590
- Sarah E. Wheeler$504,619
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortObesityCaliforniaDiabetes MellitusChildAffectWomanRisk FactorsRaceGrowthSamplingPathway InteractionsLife StyleMental DepressionPregnancyMothersDietBirthBody Mass IndexResourcesClinical ResearchEthnic OriginVisitPhysical Activity
Grant awards (42)
Preconception and Prenatal Health Impacting Factors and Child Health$6,495,276
UH3 · FY2025 · OD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$2,970,993
UH3 · FY2025 · OD
Long term adverse health outcomes for women and children following SARS-CoV-2 infection during pregnancy$812,782
R01 · FY2025 · AI · contact PI
Comparing the effects of pharmacological treatment for gestational diabetes on long-term maternal and child health outcomes$672,314
R01 · FY2025 · DK · contact PI
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age$9,288,613
U19 · FY2024 · AG
Preconception and Prenatal Health Impacting Factors and Child Health$4,412,251
UG3 · FY2024 · OD · contact PI
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$3,093,705
UG3 · FY2024 · OD
Long term adverse health outcomes for women and children following SARS-CoV-2 infection during pregnancy$802,563
R01 · FY2024 · AI · contact PI
Comparing the effects of pharmacological treatment for gestational diabetes on long-term maternal and child health outcomes$670,325
R01 · FY2024 · DK · contact PI
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age$249,971
U19 · FY2024 · AG
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment$3,112,927
UG3 · FY2023 · OD
Preconception and Prenatal Health Impacting Factors and Child Health$2,023,822
UG3 · FY2023 · OD · contact PI
Long term adverse health outcomes for women and children following SARS-CoV-2 infection during pregnancy$802,700
R01 · FY2023 · AI · contact PI
Impact of Sugary Beverage Taxes on Weight and Health Outcomes after 3-5 Years$707,188
R01 · FY2023 · DK
Cluster randomized trial of a mobile health intervention to achieve appropriate gestational weight gain in overweight/obese women$613,874
R01 · FY2023 · DK · contact PI
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$578,966
R01 · FY2023 · GM
Equipment Supplement for Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$29,371
R01 · FY2023 · GM
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age$10,164,185
U19 · FY2022 · AG
Impact of Sugary Beverage Taxes on Weight and Health Outcomes after 3-5 Years$732,195
R01 · FY2022 · DK
Cluster randomized trial of a mobile health intervention to achieve appropriate gestational weight gain in overweight/obese women$587,915
R01 · FY2022 · DK · contact PI
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$585,886
R01 · FY2022 · GM
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age$426,092
U19 · FY2022 · AG
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age$11,145,077
U19 · FY2021 · AG
Impact of Sugary Beverage Taxes on Weight and Health Outcomes after 3-5 Years$722,508
R01 · FY2021 · DK
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$599,475
R01 · FY2021 · GM
Cluster randomized trial of a mobile health intervention to achieve appropriate gestational weight gain in overweight/obese women$591,854
R01 · FY2021 · DK · contact PI
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age$315,983
U19 · FY2021 · AG
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age$196,732
U19 · FY2021 · AG
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age$10,998,003
U19 · FY2020 · AG
Impact of Sugary Beverage Taxes on Weight and Health Outcomes after 3-5 Years$743,030
R01 · FY2020 · DK
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$624,418
R01 · FY2020 · GM
Cluster randomized trial of a mobile health intervention to achieve appropriate gestational weight gain in overweight/obese women$558,600
R01 · FY2020 · DK · contact PI
Cluster randomized trial of a mobile health intervention to achieve appropriate gestational weight gain in overweight/obese women$647,648
R01 · FY2019 · DK · contact PI
Discovery of Pharmacogenomic Biomarkers for Metformin Response$720,081
R01 · FY2018 · GM
Discovery of Pharmacogenomic Biomarkers for Metformin Response$719,085
R01 · FY2017 · GM
Discovery of Pharmacogenomic Biomarkers for Metformin Response$803,285
R01 · FY2016 · GM
Equipment Supplement due 5/20/2016 P0516422$24,942
R01 · FY2016 · GM
Discovery of Pharmacogenomic Biomarkers for Metformin Response$837,363
R01 · FY2015 · GM
Pregravid biomarkers of GDM risk, fetal growth and progression to diabetes$450,487
R01 · FY2013 · HD · contact PI
Pregravid biomarkers of GDM risk, fetal growth and progression to diabetes$487,498
R01 · FY2012 · HD · contact PI
Pregravid biomarkers of GDM risk, fetal growth and progression to diabetes$541,572
R01 · FY2011 · HD · contact PI
Pregravid biomarkers of GDM risk, fetal growth and progression to diabetes$544,432
R01 · FY2010 · HD · contact PI